The parent company of BioLife is Takeda.
Understanding the Relationship
BioLife Plasma Services, a leading global collector of high-quality plasma, operates as a key subsidiary of Takeda Pharmaceutical Company Limited. Takeda is a renowned biopharmaceutical company with a significant global presence, focusing on innovation to deliver life-changing treatments.
Takeda's Core Identity and Mission
As BioLife's parent company, Takeda is characterized by its foundational principles:
- Patient-Focused: Takeda is deeply committed to addressing unmet medical needs and improving the lives of patients worldwide.
- Values-Based: The company operates on a strong set of ethical values, ensuring integrity and responsibility in all its endeavors.
- R&D-Driven: Takeda consistently invests in research and development to discover and deliver novel medicines that provide significant therapeutic benefits.
Together, BioLife and Takeda form a unified, purpose-driven, and patient-centric organization. Their combined efforts are dedicated to providing essential medicines that offer hope for better health and a brighter future to individuals grappling with various conditions. BioLife's role in collecting plasma is critical, as this raw material is vital for the development of plasma-derived therapies that treat rare and complex diseases, directly contributing to Takeda's mission to deliver transformative healthcare solutions.
For more information about Takeda and its extensive global operations, you can visit the official Takeda website.
